Peptide Vaccination Against PD-L1 With IO103 a Novel Immune Modulatory Vaccine in Multiple Myeloma: A Phase I First-in-Human Trial

por Jørgensen, Nicolai Grønne, Klausen, Uffe, Grauslund, Jacob Handlos, Helleberg, Carsten, Aagaard, Thomas Granum, Do, Trung Hieu, Ahmad, Shamaila Munir, Olsen, Lars Rønn, Klausen, Tobias Wirenfeldt, Breinholt, Marie Fredslund, Hansen, Morten, Martinenaite, Evelina, Met, Özcan, Svane, Inge Marie, Knudsen, Lene Meldgaard, Andersen, Mads Hald
Publicado 2020

Ixazomib-thalidomide-low dose dexamethasone induction followed by maintenance therapy with ixazomib or placebo in newly diagnosed multiple myeloma patients not eligible for autolog...

por Zweegman, Sonja, Stege, Claudia A.M., Haukas, Einar, Schjesvold, Fredrik H., Levin, Mark-David, Waage, Anders, Leys, Rineke B.L., Klein, Saskia K., Szatkowski, Damian, Axelsson, Per, Do, Trung Hieu, Knut-Bojanowska, Dorota, van der Spek, Ellen, Svirskaite, Asta, Klostergaard, Anja, Salomo, Morten, Blimark, Celine, Ypma, Paula F., Mellqvist, Ulf-Hendrik, Poddighe, Pino J., Stevens-Kroef, Marian, van de Donk, Niels W.C.J., Sonneveld, Pieter, Hansson, Markus, van der Holt, Bronno, Abildgaard, Niels
Publicado 2020